CapsoVision CV
NASDAQ CV
$5.91 -0.21 (-3.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

CapsoVision (CV) Exchange Rate Effect (2024 - 2025)

CapsoVision (CV) posted Exchange Rate Effect of $4000.0 for Q4 2025, down 66.67% sequentially from $12000.0 in Q3 2025, and up 104.88% YoY from $1952.4 in Q4 2024.

CapsoVision (CV) Exchange Rate Effect (2024 - 2025) Analysis & Trends

CapsoVision has reported Exchange Rate Effect for 2 years, with the latest figure at $4000.0 in Q4 2025.

  • Quarterly Exchange Rate Effect rose 104.88% year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$27000.0 (changed N/A YoY) and the FY2025 annual result came in at $143000.0, up 304.29% from the prior year.
  • Exchange Rate Effect fell to $4000.0 in Q4 2025 per CV's latest filing, from $12000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $39000.0 in Q3 2024 and troughed at -$82000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 4.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -14.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 33.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 1.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 3.80 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -4.90 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 38.36 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -2.30 Mn
10 CapsoVision 295.13 Mn 286.05 Mn 1.87 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 12,000.00
Sep 30, 2025 12,000.00
Dec 31, 2024 -82,000.00
Dec 31, 2024 -82,000.00
Sep 30, 2024 39,000.00
Sep 30, 2024 39,000.00